GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (FRA:2O9) » Definitions » EV-to-Revenue

Renalytix (FRA:2O9) EV-to-Revenue : 20.23 (As of May. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Renalytix EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Renalytix's enterprise value is €41.47 Mil. Renalytix's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €2.05 Mil. Therefore, Renalytix's EV-to-Revenue for today is 20.23.

The historical rank and industry rank for Renalytix's EV-to-Revenue or its related term are showing as below:

FRA:2O9' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.77   Med: 29.39   Max: 2412.95
Current: 20.14

During the past 6 years, the highest EV-to-Revenue of Renalytix was 2412.95. The lowest was 4.77. And the median was 29.39.

FRA:2O9's EV-to-Revenue is ranked worse than
94.86% of 662 companies
in the Healthcare Providers & Services industry
Industry Median: 1.86 vs FRA:2O9: 20.14

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), Renalytix's stock price is €0.238. Renalytix's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.02. Therefore, Renalytix's PS Ratio for today is 10.82.


Renalytix EV-to-Revenue Historical Data

The historical data trend for Renalytix's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix EV-to-Revenue Chart

Renalytix Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-Revenue
Get a 7-Day Free Trial - - 683.82 22.79 35.46

Renalytix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.98 35.46 23.25 8.67 24.91

Competitive Comparison of Renalytix's EV-to-Revenue

For the Health Information Services subindustry, Renalytix's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renalytix's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Renalytix's EV-to-Revenue falls into.



Renalytix EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Renalytix's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=41.465/2.05
=20.23

Renalytix's current Enterprise Value is €41.47 Mil.
Renalytix's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renalytix  (FRA:2O9) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Renalytix's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.238/0.022
=10.82

Renalytix's share price for today is €0.238.
Renalytix's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renalytix EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Renalytix's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Renalytix (FRA:2O9) Business Description

Traded in Other Exchanges
Address
5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (FRA:2O9) Headlines

No Headlines